These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2654556)

  • 1. HPLC-32P-postlabelling analysis of 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine.
    Watson WP; Crane AE
    Mutagenesis; 1989 Jan; 4(1):75-7. PubMed ID: 2654556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two ultrasensitive methods for measuring 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine in cellular DNA.
    Misra RR; Chiang SY; Swenberg JA
    Carcinogenesis; 1994 Aug; 15(8):1647-52. PubMed ID: 8055645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine by immunoaffinity/32P-postlabelling in liver and lung DNA of mice treated with ethyl carbamate (urethane) or its metabolites.
    Fernando RC; Nair J; Barbin A; Miller JA; Bartsch H
    Carcinogenesis; 1996 Aug; 17(8):1711-8. PubMed ID: 8761431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabeling.
    Nair J; Barbin A; Guichard Y; Bartsch H
    Carcinogenesis; 1995 Mar; 16(3):613-7. PubMed ID: 7697821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of etheno adducts by fluorescence detection.
    Bedell MA; Dyroff MC; Doerjer G; Swenberg JA
    IARC Sci Publ; 1986; (70):425-36. PubMed ID: 3491789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine occurring endogenously in DNA.
    Watson WP; Aston JP; Barlow T; Crane AE; Potter D; Brown T
    IARC Sci Publ; 1999; (150):63-73. PubMed ID: 10626209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some quantitative considerations about DNA adduct enrichment procedures for 32P-postlabelling.
    Vaca CE; Löfgren M; Hemminki K
    Carcinogenesis; 1992 Dec; 13(12):2463-6. PubMed ID: 1473258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and kinetic examination of 32P-postlabeling of etheno-substituted nucleotides.
    Szyfter K; Hemminki K; Crane AE; Watson WP
    Chem Biol Interact; 1991; 80(1):99-107. PubMed ID: 1913981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoaffinity clean-up combined with 32P-postlabelling analysis of 1,N6-ethenoadenine and 3,N4-ethenocytosine in DNA.
    Guichard Y; Nair J; Barbin A; Bartsch H
    IARC Sci Publ; 1993; (124):263-9. PubMed ID: 8225494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid peroxidation-induced etheno-DNA adducts in humans.
    Nair J
    IARC Sci Publ; 1999; (150):55-61. PubMed ID: 10626208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a 32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA.
    Fang JL; Vaca CE
    Carcinogenesis; 1995 Sep; 16(9):2177-85. PubMed ID: 7554072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a 32P-postlabelling method for the analysis of 2'-deoxyguanosine-3'-monophosphate and DNA adducts of methylglyoxal.
    Vaca CE; Fang JL; Conradi M; Hou SM
    Carcinogenesis; 1994 Sep; 15(9):1887-94. PubMed ID: 7923582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of malonaldehyde-modified 2'-deoxyguanosine-3'-monophosphate and DNA by 32P-postlabelling.
    Vaca CE; Vodicka P; Hemminki K
    Carcinogenesis; 1992 Apr; 13(4):593-9. PubMed ID: 1576712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular response to exocyclic DNA adducts.
    Moriya M; Pandya GA; Johnson F; Grollman AP
    IARC Sci Publ; 1999; (150):263-70. PubMed ID: 10626226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent increase of etheno-DNA-adducts in liver and brain of ROS overproducing OXYS rats.
    Nair J; Sinitsina O; Vasunina EA; Nevinsky GA; Laval J; Bartsch H
    Biochem Biophys Res Commun; 2005 Oct; 336(2):478-82. PubMed ID: 16137653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.
    Kumar R; Staffas J; Försti A; Hemminki K
    Carcinogenesis; 1995 Mar; 16(3):483-9. PubMed ID: 7697802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.
    Försti A; Staffas J; Hemminki K
    Carcinogenesis; 1994 Dec; 15(12):2829-34. PubMed ID: 8001242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.